INTERfering and Co-Evolving Prevention and Therapy

Archived

DARPA - Biological Technologies Office

Description

Under the INTERCEPT BAA-16-35, DARPA is soliciting innovative proposals for research to explore and develop therapeutic interfering particles as a novel approach to address infections from fast evolving viral pathogens.

Who can apply

  • Unrestricted

Contact

James Gimlett, Ph.D. Program Manager <br/>Biological Technologies Office (BTO)
DARPA-BAA-16-35@darpa.mil

Key dates & funding
  • PostedApr 28, 2016
  • ClosesJul 7, 2016
  • CFDA12.910

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro